Equities researchers at Zacks Research lifted their Q2 2025 earnings per share estimates for shares of Bausch Health ...
Rithm Capital Corp. (NYSE:RITM – Get Free Report) has received an average rating of “Buy” from the six analysts that are currently covering the company, MarketBeat reports. One investment analyst has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results